FC
KALA icon

FORA Capital’s KALA BIO KALA Stock Holding History

FORA Capital’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2
Closed -$47K – 1113
2020
Q1 		$47K Buy
+2
New +$32K 0.01% 781

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's KALA Position: Q2 2020 in Review

FORA Capital sold out of KALA BIO (KALA) in Q2 2020, closing a stake of 2 shares — an estimated $47K sold.

FORA Capital first reported a position in KALA in Q1 2020 and held it in 1 quarter. The position peaked at $47K in Q1 2020. 113 funds tracked by Wall St. Rank hold KALA as of Q2 2020.

  • FORA Capital reported no remaining KALA BIO position as of Q2 2020 after selling out during the quarter.
  • FORA Capital sold 2 KALA BIO shares in Q2 2020, an estimated $47K.
  • FORA Capital first reported a position in KALA BIO in Q1 2020 and held it in 1 quarter.
  • FORA Capital's KALA BIO position peaked at $47K in Q1 2020.
  • 113 funds tracked by Wall St. Rank held KALA BIO as of Q2 2020.

Based on FORA Capital's 13F filing for Q2 2020, filed 14 Aug 2020.